Brainnatriuretic peptide M-atrial natriuretic peptide: A Novel Cardiovascular Agent
M-atrial natriuretic peptide (MANP) represents a significant development in the understanding and therapeutic application of natriuretic peptides, a family of hormones crucial for cardiovascular homeostasisSua principal função éregular a pressão arterial e o volume de fluidos no corpo, atuando como um agente natriurético, ou seja, promovendo a excreção de sódio .... Engineered as a more potent and longer-lasting analog of the native atrial natriuretic peptide (ANP), MANP has demonstrated promising effects in regulating blood pressure and fluid balance. This peptide is a subject of considerable research, exploring its complex actions on the cardiovascular system, its potential as an antihypertensive agent, and its role in conditions such as heart failure and metabolic syndrome.
Atrial natriuretic peptide (ANP) is a hormone primarily secreted by the cardiac myocytes of the right atrium作者：T Maack·2006·被引用次数：143—A brief non-inclusive review onnatriuretic peptides(NP), their receptors, and their main functional properties is presented.. Its release is triggered by atrial stretch, which often occurs due to increased blood volume or elevated blood pressure. ANP plays a vital role in the body's intricate system for maintaining fluid and electrolyte balance, and consequently, blood pressure. Its primary functions include promoting natriuresis (excretion of sodium) and diuresis (excretion of water) by the kidneys, leading to a reduction in blood volume and blood pressure. Additionally, ANP has vasodilatory effects, further contributing to lower blood pressure.
Recognizing the therapeutic potential of ANP, researchers engineered M-atrial natriuretic peptide (MANP) to overcome some limitations of the native peptideMANP (M-Atrial Natriuretic Peptide) Reduces Blood .... MANP is a novel ANP-based peptide designed to be more resistant to proteolytic degradation, thereby extending its duration of action. This enhanced stability and potency make MANP a more effective agent for therapeutic interventionsIt is produced in cardiac myocytes, where it exerts vasodilating effects, hence playing an important role in the regulation of blood pressure and natriuresis/ .... Studies have shown that MANP can exert pleiotropic effects, including significant blood pressure-lowering capabilities. Furthermore, MANP has been investigated for its ability to potentiate the effects of other medications, such as furosemide, and to suppress the renin-angiotensin-aldosterone system, a key regulator of blood pressure.作者：T Maack·2006·被引用次数：143—A brief non-inclusive review onnatriuretic peptides(NP), their receptors, and their main functional properties is presented.
The research surrounding M-atrial natriuretic peptide is largely focused on its potential as a treatment for hypertension and related cardiovascular conditions. Clinical studies have indicated that MANP is safe and well-tolerated, with notable blood pressure-lowering effects作者：NA Dzhoyashvili·2022·被引用次数：8—We provide novel evidence thatMANP potentiates the BP-lowering actions of furosemide, suppresses the activation of renin-angiotensin-aldosterone system, and .... Its capacity to improve renal function and reduce aldosterone levels further underscores its therapeutic promise. Beyond hypertension, MANP's influence on fluid and electrolyte balance suggests potential applications in managing heart failure, where fluid overload is a critical concern.作者：TJ Wang·2004·被引用次数：2040—Atrial natriuretic peptide and B-type natriuretic peptide aresecreted from cardiomyocytes in response to atrial or ventricular wall stretch. The natriuretic ... While the B-type natriuretic peptide (BNP) test is commonly used to diagnose or rule out heart failure, MANP represents a novel therapeutic approach rather than a diagnostic markerPlasma A- and B-type natriuretic peptides - Oxford Academic.
Emerging research also highlights the role of M-atrial natriuretic peptide in conditions like metabolic syndrome, which is often associated with hypertension and cardiovascular risks作者：HH Chen·2021·被引用次数：43—M-atrial natriuretic peptide (MANP) is a novel ANP analog that was engineered at the Mayo Clinic to be more potent and long-lasting than native .... Proof-of-concept studies have explored the impact of MANP in individuals with hypertension and metabolic syndrome, suggesting that it may offer benefits beyond just blood pressure reduction, potentially addressing some of the metabolic derangements associated with the syndrome.
The development of M-atrial natriuretic peptide signifies a step forward in leveraging the body's natural mechanisms for cardiovascular regulation.MANP (M-Atrial Natriuretic Peptide) Reduces Blood ... As research continues, MANP holds promise as a novel therapeutic peptide for a range of cardiovascular and metabolic disorders. Its enhanced potency and duration of action compared to native ANP position it as a compelling candidate for further clinical investigation and potential integration into treatment strategies for conditions affecting blood pressure and fluid homeostasis.Natriuretic Peptide Tests (BNP, NT-proBNP)
Join the newsletter to receive news, updates, new products and freebies in your inbox.